https://www.selleckchem.com/pr....oducts/ulixertinib-b
001), and all of them had developed complex SAS at titration night requiring other modes of positive airway pressure therapy than the continuous mode (P = 0.004). Curve estimation models showed that the change from mixed apneas to central apneas was highly significant in patients developing complex SAS (r2 = 0.501; P = 0.022). Our study showed that the summation of mixed apneas with the obstructive events conventionally underestimates the central components and the diagnosis of central SAS, which are fundamental in